RETRACTION: FOXK1 promotes malignant progression of breast cancer by activating PI3K/AKT/mTOR signaling pathway (Retraction of Vol 23, Pg 9978, 2019)

被引：4
|
作者：
Li, Z. -Q. [1 ]
Qu, M. [1 ]
Wan, H. -X. [1 ]
Wang, H. [1 ]
Deng, Q. [1 ]
Zhang, Y. [1 ]
机构：
[1] Sanya Peoples Hosp, Dept Oncol, Sanya, Peoples R China
来源：
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES | 2021年 / 25卷 / 05期
关键词：
D O I：
10.26355/eurrev_202103_25247
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：2159 / 2159
页数：1
相关论文
共 50 条
  • [21] MFAP2 promotes the malignant progression of gastric cancer via activating the PI3K/AKT signaling pathway
    Guo, Peng
    Dai, Ting
    Jin, Xiaohu
    Wu, Hao
    Qiu, Shengkui
    Tang, Chong
    Feng, Shichun
    JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, 2025,
  • [22] RETRACTION: Rapamycin suppresses the PI3K/AKT/mTOR signaling pathway by targeting SIRT1 in esophageal cancer (Retraction of Vol 22, art no 1190, 2021)
    Liu, Tao
    Liang, Xiangsen
    Sun, Yu
    Yang, Shengzhuang
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2024, 27 (01)
  • [23] PI3K/AKT/mTOR signaling pathway modulation by circular RNAs in breast cancer progression
    Fath, Mohsen Karami
    Masouleh, Ramtin Akhavan
    Afifi, Negin
    Loghmani, Shirin
    Tamimi, Parham
    Fazeli, Alireza
    Mousavian, Seyed Ali
    Falsafi, Mohammad Mehdi
    Barati, Ghasem
    PATHOLOGY RESEARCH AND PRACTICE, 2023, 241
  • [24] RETRACTION: Inhibitory role of large intergenic noncoding RNA-ROR on tamoxifen resistance in the endocrine therapy of breast cancer by regulating the PI3K/Akt/mTOR signaling pathway (Retraction of Vol 234, Pg 1904, 2019)
    Lu, Peng-Wei
    Li, Lin
    Wang, Fang
    Gu, Yuan-Ting
    JOURNAL OF CELLULAR PHYSIOLOGY, 2022, 237 (03) : 2004 - 2004
  • [25] PODXL promotes malignant progression of hepatocellular carcinoma by activating PI3K/AKT pathway
    Ding, Yifeng
    Wang, Xiaoqing
    Shu, Fei
    Pan, Kehua
    Chen, Xiaohong
    Liu, Qingquan
    JOURNAL OF MOLECULAR HISTOLOGY, 2024, 55 (06) : 1107 - 1120
  • [26] SLC26A9 promotes the initiation and progression of breast cancer by activating the PI3K/AKT signaling pathway
    Ma, Zhiyuan
    Wang, Hu
    Zhou, Zhengxing
    Lu, Chengli
    Zhang, Minglin
    Mu, Renmin
    Zhang, Chengmin
    Yi, Zhiqiang
    Deng, Zilin
    Zhao, Yingying
    Zhu, Jiaxing
    Wen, Guorong
    Jin, Hai
    An, Jiaxing
    Tuo, Biguang
    Yuan, Peng
    Liu, Xuemei
    Li, Taolang
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2025, 1872 (03):
  • [27] RETRACTION: Oxymatrine Inhibits the Proliferation and Invasion of Breast Cancer Cells via the PI3K Pathway (Retraction of Vol 11, Pg 10499, 2019)
    Guo, L.
    Yang, T.
    CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 2289 - 2289
  • [28] RETRACTION: Fangchinoline targets PI3K and suppresses PI3K/AKT signaling pathway in SGC7901 cells (Retraction of Vol 46, Pg 2355, 2015)
    Tian, Feng
    Ding, Ding
    Li, Dandan
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2023, 63 (03)
  • [29] RETRACTION: GABARAP promotes bone marrow mesenchymal stem cells-based the osteoarthritis cartilage regeneration through the inhibition of PI3K/AKT/mTOR signaling pathway (Retraction of Vol 234, Pg 21014, 2019)
    Wu, Zhengyuan
    Lu, Huiping
    Yao, Jun
    Zhang, Xiaohan
    Huang, Yimei
    Ma, Shiting
    Zou, Kai
    Wei, Yan
    Yang, Zhengyi
    Li, Jia
    Zhao, Jinmin
    JOURNAL OF CELLULAR PHYSIOLOGY, 2021, 236 (05) : 4092 - 4092
  • [30] RETRACTION: MicroRNA-367 promotes progression of hepatocellular carcinoma through PTEN/PI3K/AKT signaling pathway (Retraction of art no BSR20182466, 2019)
    Wang, Zihua
    Luo, Yu
    BIOSCIENCE REPORTS, 2020, 40
12345